Related Experiment Video
Updated: Jun 10, 2026
08:21
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
JAK/STAT signaling in renal diseases
1Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.
Kidney International
|July 16, 2010
Summary
Activation of STAT3, a key component of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway, drives kidney fibrosis. This research confirms STAT3
Area of Science:
- Molecular Biology
- Renal Physiology
- Cell Signaling
Background:
- The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway regulates critical cellular processes.
- JAK/STAT signaling is integral to the kidney's response to injury and disease.
- STAT3 activation has been implicated in various fibrotic conditions.
Discussion:
- Pang et al. investigated the role of STAT3 in renal fibrosis using a unilateral ureteral obstruction model.
- The study confirms that STAT3 activation is a critical mediator of renal fibrotic responses.
- This highlights the JAK/STAT pathway's significance in kidney injury pathogenesis.
Key Insights:
- STAT3 activation directly contributes to the development of renal fibrosis.
- The unilateral ureteral obstruction model effectively demonstrates STAT3's role in kidney damage.
- Targeting STAT3 may offer a therapeutic strategy for kidney fibrosis.
Outlook:
- Further research can explore specific upstream activators of STAT3 in renal injury.
- Investigating downstream targets of STAT3 will elucidate fibrotic mechanisms.
- Developing STAT3 inhibitors could be a promising avenue for treating kidney fibrosis.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:29Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
01:45Endocrine Signaling
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...